Sangeeta Dnyaneshwar Palekar

Dr. Sangeeta Dnyaneshwar Palekar

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
SPSangeeta Dnyaneshwar Palekar
Sangeeta Dnyaneshwar Palekar
SKSharayu Kalambe
Sharayu Kalambe
JKJayu Kalambe
Jayu Kalambe
Madhusudan KulkarniMadhusudan Kulkarni
Madhusudan Kulkarni
Manish BhaiyyaManish Bhaiyya
Manish Bhaiyya
Detecting kidney function biomarkers is critical for the early diagnosis of kidney diseases and monitoring treatment efficacy. In this work, a portable, 3D-printed colorimetric sensor platform was developed to detect key kidney biomarkers: uric acid, creatinine, and albumin. The platform features a 3D-printed enclosure with integrated diffused LED lighting to ensure a controlled environment for image acquisition. A disposable 3D-printed flow cell holds samples, ensuring precision and minimizing contamination. The sensor relies on colorimetric analysis, where a reagent reacts with blood serum to produce a color shift proportional to the biomarker concentration. Using a smartphone, the color change is captured, and RGB values are normalized to calculate concentrations based on the Beer-Lambert Law. The system adapts to variations in smartphones, reagent brands, and lighting conditions through an adaptive calibration algorithm, ensuring flexibility and accuracy. The sensor demonstrated good linear detection ranges for uric acid (1–30 mg/dL), creatinine (0.1–20 mg/dL), and albumin (0.1–8 g/dL), with detection limits of 1.15 mg/dL, 0.15 mg/dL, and 0.11 g/dL, respectively. These results correlated well with commercial biochemistry analyzers. Additionally, an Android application was developed to handle image processing and database management, providing a user-friendly interface for real-time blood analysis. This portable, cost-effective platform shows significant potential for point-of-care diagnostics and remote health monitoring.

21 November 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NINeha Ingole
Neha Ingole
SPSangeeta Dnyaneshwar Palekar
Sangeeta Dnyaneshwar Palekar
Madhusudan KulkarniMadhusudan Kulkarni
Madhusudan Kulkarni
JKJayu Kalambe
Jayu Kalambe
RKRicha Khandelwal
Richa Khandelwal
Accurate and decentralized liver biomarker testing is critical for early diagnosis and monitoring of hepatic dysfunctions, particularly in resource-constrained settings. This work presents a novel smartphone-integrated colorimetric sensing platform that combines microfluidics, deep learning, and mobile health technologies to estimate liver biomarkers quantitatively. A stereolithography (SLA) 3D-printed microfluidic flow cell, optimized for low reagent use and high optical clarity, processes 100 µL of sample-reagent mixture via a peristaltic pump at 50 µL/s. Biomarker-specific chromogenic reactions are imaged within a controlled lighting enclosure using multiple smartphone models and analyzed using a convolutional neural network (CNN) for a regression approach. The system achieves clinically relevant detection ranges of 0.1–20 mg/dL for direct and total bilirubin, and 10–300 U/L for alanine aminotransferase (ALT) and aspartate aminotransferase (AST), with limits of detection of 0.1 mg/dL, 0.05 mg/dL, 2.97 U/L, and 2.5 U/L, respectively. A two-point smartphone adaptability framework ensures robust cross-device performance without retraining. An Android application has been developed, which provides users with disease identification, real-time inference, and visualization of result. This clinical-grade analyzer features an average coefficient of determination (R 2 ) of 0.997 for all biomarkers, and the repeatability is shown by coefficients of variation under 3%. This innovative, cost-effective and portable solution gives precise liver function assessment, making it ideal for rural healthcare and mobile diagnostics.

27 August 2021 in IEEE Sensors Journal
Verified
Journal Article
Closed access
SPSangeeta Dnyaneshwar Palekar
Sangeeta Dnyaneshwar Palekar
JKJayu Kalambe
Jayu Kalambe
The development of a cost-efficient and sensitive platform for biochemical analysis of blood serum and its realization in the low resource areas is one of the imperative challenges to establish a robust healthcare ecosystem. The present work demonstrates the design of a universal platform, capable of performing all biochemical analyses of blood serum by measuring the absorbance of light through the test sample. To verify the working of the developed platform, the concentration of glucose was estimated in blood serum. The detection of glucose has been accomplished in a linear range of 1 mg/dL to 400 mg/dL with detection of limit 1 mg/dL ( $\text{R}^{2} =0.9875$ , n = 3). The stability analysis demonstrates improved stability in the output as compared to the conventional analyzer with an average standard deviation of 0.32 calculated for n = 5. Human blood samples were tested with the developed platform and the results were in line with the pathology laboratory. The developed platform offers the advantages of automation, low cost, portability, simple instrumentation, flexibility, and an easily accessible interface. Due to the use of a huge processing capability processor, the analysis time reduces to half a minute which yields fast analysis and high throughput. The stability and accuracy also improve owing to the employment of high-resolution electronics components. Overall, the proposed framework is an attractive solution to be incorporated in the low resource area as a universal platform for all biochemistry analysis simply by varying the wavelength of light and reagent.

30 September 2022 in IEEE Sensors Journal
Verified
Journal Article
Closed access
SPSangeeta Dnyaneshwar Palekar
Sangeeta Dnyaneshwar Palekar
JKJayu Kalambe
Jayu Kalambe
RPRajendra M. Patrikar
Rajendra M. Patrikar
A fully integrated biochemical sensing platform is developed for blood diagnostics. The biochemical analyses of blood include the enzymatic reaction of the sample with a reagent that produces a colorimetric variation of solutions. The developed platform focuses on providing software solutions to the hardware dependencies in the existing analyzers by replacing the physical optical filter wheel assembly with software-based wavelength filtering. The experiments are performed to sense these variations with the developed image acquisition platform and the software-based wavelength filtering unit. The machine learning approach is used to train the system to predict unknown concentrations using the experimentally generated dataset. To verify the usability of the developed platform, the sensing of glucose, albumin, and cholesterol was carried out in the linear range from 10 to 400 mg/dL, from 1 to 8 g/dL, and from 10 to 800 mg/dL with a limit of detection (LOD) of 2.8 mg/dL, 0.64 g/dL, and 3.14 mg/dL, respectively. The results obtained are matching with the commercial biochemistry analyzer. The system is tested thoroughly, and the results show that the developed blood sensing platform is reliable, portable, and accurate due to the minimization of hardware moving parts, and offers extreme flexibility of operation due to software solutions, facilitating numerous blood analysis all-in-one instruments.

3 February 2023 in Chemical Papers
Verified
Journal Article
Closed access
PDF file
SPSangeeta Dnyaneshwar Palekar
Sangeeta Dnyaneshwar Palekar
JKJayu Kalambe
Jayu Kalambe
RPRajendra M. Patrikar
Rajendra M. Patrikar

1 February 2024 in ECS Journal of Solid State Science and Technology
Verified
Journal Article
Closed access
SPSangeeta Dnyaneshwar Palekar
Sangeeta Dnyaneshwar Palekar
JKJayu Kalambe
Jayu Kalambe
RPRajendra M. Patrikar
Rajendra M. Patrikar
The pursuit of rapid diagnosis has resulted in considerable advances in blood parameter sensing technologies. As advances in technology, there may be challenges in equitable access for all individuals due to economic constraints, advanced expertise, limited accessibility in particular places, or insufficient infrastructure. Hence, simple, cost efficient, benchtop biochemical blood-sensing platform was developed for detecting crucial blood parameters for multiple disease diagnosis. Colorimetric and image processing techniques is used to evaluate color intensity. CMOS image sensor is utilized to capture images to calculate optical density for sensing. The platform is assessed with blood serum samples, including Albumin, Gamma Glutamyl Transferase, Alpha Amylase, Alkaline Phosphatase, Bilirubin, and Total Protein within clinically relevant limits. The platform had excellent Limits of Detection (LOD) for these parameters, which are critical for diagnosing liver and kidney-related diseases (0.27 g dl−1, 0.86 IU l−1, 1.24 IU l−1, 0.97 IU l−1, 0.24 mg dl−1, 0.35 g dl−1, respectively). Machine learning (ML) algorithms were used to estimate targeted blood parameter concentrations from optical density readings, with 98.48% accuracy and reduced incubation time by nearly 80%. The proposed platform is compared to commercial analyzers, which demonstrate excellent accuracy and reproducibility with remarkable precision (0.03 to 0.71%CV). The platform’s robust stability of 99.84% was shown via stability analysis, indicating its practical applicability.